We are monitoring the impact of COVID-19 on Cell Therapy Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 11415
Share on
Share on

Global Cell Therapy Market Size, Share, Trends, Growth & COVID-19 Impact Analysis Report – Segmented By Technology, Type, Cell Source, Application, End-Users and Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: April, 2021
ID: 11415
Pages: 190

Cell Therapy Market Size (2021 to 2026)

As per our report, the size of the global cell therapy market is estimated to be at a remarkable CAGR of 31.7% during the forecast period. Cell therapies have a lot of advancement in treating a variety of diseases. Many trials are currently underway in the race among countries and companies to develop effective COVID-19 vaccines and therapeutics. To ensure the safety and effectiveness of stem cell therapy, the researcher must perform clinical trials. Understanding the nature of stem cells is a long way from using them therapeutically. There are many hopes for cell therapy of human diseases, but there are still many issues to work out. There is optimism that cell therapy will be approved to treat viral diseases like COVID-19 in the future; it will boost the cell therapy market in the forecast period.

The transfer of intact, live cells or cure a disease into a patient to help lessen is known as cell therapy. The cells can come from the patient (autologous cells) or a donor (allogeneic cells). In cell therapy, the ability of cells used to convert into various cell types can be categorized. Pluripotent cells can convert into any cell type in the body, while multipotent cells can transform into other cell types but with a smaller range than pluripotent cells. The treatment determines the type of cells used. It helps to replace missing or diseased cells in a patient's body with new, healthy cells.

MARKET DRIVERS:

Continuous growing regulatory approval of cell therapy products for various disorders is expected to drive growth for the global cell therapy market.

Adult aggressive B-cell lymphomas (Yescarta and Kymriah), young adults (Kymriah), and B-cell leukemia in children, most recently, relapsed or refractory mantle cell lymphoma (MCL) in adults have all been authorized by the FDA (Tecartus). Swedish Cancer Institute is pleased to provide Chimeric Antigen Receptor (CAR)-T cell therapy to eligible patients. CAR-T cell therapy is a relatively new form of immunotherapy that has resulted in widespread patient remission since its approval in 2017. Insurance firms are also developing plans for FDA-approved treatments, including CAR-T cell therapy, although it was only recently approved for use in April 2017.

Increased application of human cells in cell therapy research and technical advances in cell therapy and the rising of Preclinical and clinical trials of cell therapy for various lung disorders.

In addition to cancer and cardiovascular disease, lung diseases are a leading cause of morbidity and death globally. There are curative treatments and no safe options for certain disease conditions. Because of their anti-fibrotic effects and intrinsic anti-inflammatory, cell therapies represent a novel therapeutic approach. The mesenchymal stem/stromal cells (MSC) are the most researched cell product for various diseases. MSCs are a promising therapeutic method for the treatment of lung diseases in preclinical & clinical trials. About 350 clinical trials using mesenchymal cells are currently in progress around the world. Several studies are focusing on rheumatology (osteoarthritis, rheumatoid arthritis), cardiology (stroke, myocardial infarction, ischemia of the lower limbs), muscle degeneration (myopathy), diabetes, graft rejection, autoimmune disease (lupus), and other chronic disorders.

The growth of regenerative medicine is expected to boost the global cell therapy market rapidly.

Regenerative treatments, including both gene and cellular therapies, seek to stimulate cell, tissue, and organ regeneration and restore function. Human embryonic stem cells differentiated into retinal cells are used to treat differentiated into retinal pigment epithelial cells, and AMD is used to treat Stargardt's disease by a US biotech company (Ocata Therapeutics). In both cases, phase I and II trials are ongoing to assess the therapeutic efficacy and approach's safety. The initial findings are encouraging but modest. Another AMD trial is being designed by The London Project to Cure Blindness by collaboration with a pharmaceutical firm (Pfizer). Seeding cells onto biomimetic or natural scaffolds produces bioartificial tissues (tissue engineering).

The rising prevalence of chronic diseases such as cancer and cardiac disorders is predicted to accelerate the growth rate of the global cell therapy market.

According to WHO, Cancer is one of the world's leading causes of death, with about 9.6 million deaths in 2018. Africa, Asia, and Central and South America account for more than 60% of all new cases worldwide each year. Seventy percent of all cancer deaths occur in these areas. Lung, colorectal, stomach, liver, and breast cancers account for most cancer deaths per year. Cancer is the leading cause of death worldwide, with almost 10 million deaths expected by 2020. Cardiovascular diseases (CVDs) are the leading cause of death worldwide, claiming the lives of around 17.9 million people per year. Representing 31% of all deaths worldwide, and Heart attacks & strokes account for 85% of these deaths.

Furthermore, the global cell therapy industry is being driven by rising government initiatives aimed at raising awareness of cell therapy in healthcare facilities in developed countries and encouraging cancer-cell therapy research, as well as the world's growing geriatric population.

MARKET RESTRAINTS:

The availability of sufficient cells for transplantation into a patient is a problem for this form of therapy. This is due to the difficulty of obtaining specialized cells from the human body, such as brain cells. Furthermore, since specialized cells can generate sufficient numbers of cells for certain cell therapies, having a limited ability to replicate can be challenging. Costly treatment and poorly designed reimbursement programs, and difficulties associated with the CAR-T cell logistical and production process challenges faced by healthcare organizations are impeding the development of the market. Some people have had serious side effects due to this procedure, particularly as the CAR T cells multiply in the body to fight cancer, reported by the American Cancer Society. Another issue is that some healthy B cells that help fight infection would be destroyed by the cells, placing the patient at risk of infection. In the healthcare sector, there is a shortage of professionals and staff. Restriction of regulatory approval of the cell therapy product.

Impact of COVID-19 on the global cell therapy market:

The COVID-19 is spreading rapidly across the world. The COVID-19 pandemic is currently affecting the availability of crucial routine healthcare facilities and treatments, such as Cell therapies, CAR-T therapy, a life-saving treatment option for patients. Cell therapies have many potentials for treating various diseases, but their commercial viability has been questioned for a long time. Now, as the world struggled with an unprecedented global pandemic, it spoke with a few organizations that are either already CAR-T certified or have recently begun the process to assess COVID-19's effect on CAR-Ts. Not only for today's CAR-Ts, but also for the next wave of cell therapies, the improvements caused by the pandemic may have long-term consequences.

Also, suppliers struggle to ensure that they have access to treatments for patients and raw materials.  The already complicated cell therapy supply chain and manufacturing process have impacted negatively in a pandemic. COVID-19 has impacted cell therapy in various ways in the short term are Clinical experiments are taking a break for the time being. In certain centers, the use of CAR-T cells has decreased. Delays for facilities that have not yet been approved, as well as a renewed emphasis on telemedicine and outpatient monitoring for hospitals that began the phase before COVID-19.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2019 to 2025

Base Year

2019

Forecast Period

2020 to 2025

Segments Covered

By Technology, Type, Cell Source, Application, End-Users, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global cell therapy market has been segmented and sub-segmented based on technology, type, cell source, application, end-users, and region.

Cell Therapy Market - By Technology:

  • Somatic Cell Technology
  • Cell Immortalization Technology
  • Viral Vector Technology
  • Genome Editing Technology
  • Cell Plasticity Technology
  • Three-Dimensional Technology

The somatic cell technology market leads with the dominant shares of the market where the cell immortalization technology segment is growing faster over the past few years. Rising investments in the development of new techniques in healthcare with random technologies are a major factor for the segments to grow tremendously.

Cell Therapy Market - By Type:

  • Autologous
  • Allogeneic

The autologous segment is anticipated to rule the shares of the market in the forecast period. Rising incidences of chronic diseases and increasing elderly population are fuelling the demand of the segment to the extent.

Cell Therapy Market - By Cell Source:

  • iPSCs
  • Bone Marrow
  • Umbilical Cord Blood-Derived Cells
  • Adipose Tissues
  • Neural Stem Cell

Umbilical cord blood-derived cells segment is gaining traction over the market shares with the increasing awareness over the benefits of this procedure.

Cell Therapy Market – By Application:

  • Musculoskeletal
  • Cardiovascular
  • Gastrointestinal
  • Neurological
  • Oncology
  • Dermatology
  • Wounds & Injuries
  • Ocular
  • Others

The cardiovascular segment is growing at a higher rate and is expected to have significant growth opportunities in the coming years. The oncology application sector is likely to have the dominant shares of the market in the forecast period due to rising cancer patients worldwide.

Cell Therapy Market – By End-User:

  • Hospitals & Clinics
  • Regenerative Medicine Centres
  • Diagnostic & Research Centres
  • Others

The hospitals and clinics segment is leading with the largest shares of the market. The rising number of hospitals and the increasing patient pool is ascribed to bolster the demand of this segment.

Cell Therapy Market – By Region:

  • North America
    • The U.S.
    • Canada
    • Rest of North America
  • Europe
    • UK
    • Germany
    • Spain
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • India
    • Japan
    • China
    • Australia
    • South Korea
    • Rest of APAC
  • Latin America
    • Mexico
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East
  • Africa

Geographically, the North American cell therapy market held the largest regional market share in the global cell therapy market in 2020 and accounted for a market share of 52.7%. This regional market is primarily driven by rising healthcare costs and an increase in CVD incidence. Over the forecast period, the United States has contributed most to the North American regional market. The market is growing as people's disposable income rises and their awareness of healthcare increases. On the other hand, the Canadian market is anticipated to be the largest in the coming years.

The European market was the second-largest regional market in the global market in 2020. The growing number of clinical studies for cell-based therapies is accelerating market growth. The United Kingdom is expected to dominate the European regional market. Growing research and development activities and adopting advanced cell-based therapies are expected to contribute to the largest market share in this region.

In 2020, the APAC region was one of the fastest-growing regions in the cell therapy market. By 2025, the market is expected to have a market share of USD 4.01 billion, with a CAGR of 12.6 percent over the forecast period. As a result of the number of pharmaceutical and biotechnology industries in the APAC region, China has dominated the largest market share. On the other hand, technological advancements and increasing disposable income are most likely to augment the Cell therapy market. On the other hand, Japan is anticipated to grow with an increasing CAGR. The Indian cell-based therapy market is projected to witness a healthy market share during the forecast period. Favorable reimbursement programs and improving healthcare infrastructure and government investments are encouraging regional market growth. 

Over the forecast period, Middle East Africa is expected to have a moderate share. Factors such as a significant increase in the number of centers and institutes engaged in stem cell therapy research and innovation and rising healthcare awareness are likely to fuel market growth.

KEY MARKET PARTICIPANTS:

Some of the promising companies dominating the global cell therapy market profiled in this report are Merck KGaA and Thermo Fisher Scientific Inc, Lonza Group, Osiris Therapeutics, Inc., Danaher Corporation, Becton, Dickinson and Company, Sartorius AG, Fresenius Medical Care AG & Co. KGaA, FUJIFILM Irvine Scientific, Corning Incorporated, Mesoblast Ltd., Medipost Co., Ltd. Avantor, Inc., CellGenix GmbH, Bio-Techne Corporation, STEMCELL Technologies, SIRION Biotech GmbH, and Hemasoft.

  1. INTRODUCTION
    1. Market Definition
    2. Study Deliverables
    3. Base Currency, Base Year, and Forecast Periods
    4. General Study Assumptions
  2. RESEARCH METHODOLOGY
    1. Introduction
    2. Research Phases
      1. Secondary Research
      2. Primary Research
      3. Econometric Modelling
      4. Expert Validation
    3. Analysis Design
    4. Study Timeline
  3. Report Overview
    1. Executive Summary
    2. Key Inferences
  4. Market Dynamics
    1. Impact Analysis
      1. Drivers
      2. Restraints
      3. Opportunities       
    2. Regulatory Environment
    3. Technology Timeline & Recent Trends
  5. Competitor Benchmarking Analysis
    1. Key Player Benchmarking                    
      1. Market share analysis      
      2. Products/Service
      3. Regional Presence               
    2. Mergers & Acquisition Landscape                     
    3. Joint Ventures & Collaborations
  6. MARKET SEGMENTATION
    1. By Technology
      1. Somatic Cell Technology
      2. Cell Immortalization Technology
      3. Viral Vector Technology
      4. Genome Editing Technology
      5. Cell Plasticity Technology
      6. Three-Dimensional Technology
      7. Y-o-Y Growth Analysis, By Technology
      8. Market Attractiveness Analysis, By Technology
      9. Market Share Analysis, By Technology
    2. By Type
      1. Autologous
      2. Allogeneic
      3. Y-o-Y Growth Analysis, By Type
      4. Market Attractiveness Analysis, By Type
      5. Market Share Analysis, By Type
    3. By Cell Source
      1. iPSCs
      2. Bone Marrow
      3. Umbilical Cord Blood-Derived Cells
      4. Adipose Tissues
      5. Neural Stem Cell
      6. Y-o-Y Growth Analysis, By Cell Source
      7. Market Attractiveness Analysis, By Cell Source
      8. Market Share Analysis, By Cell Source
    4. By Application
      1. Musculoskeletal
      2. Cardiovascular
      3. Gastrointestinal
      4. Neurological
      5. Oncology
      6. Dermatology
      7. Wounds & Injuries
      8. Ocular
      9. Others
      10. Y-o-Y Growth Analysis, By Application
      11. Market Attractiveness Analysis, By Application
      12. Market Share Analysis, By Application
    5. By End-User
      1. Hospitals & Clinics
      2. Regenerative Medicine Centres
      3. Diagnostic & Research Centres
      4. Others
      5. Y-o-Y Growth Analysis, By End-User
      6. Market Attractiveness Analysis, By End-User
      7. Market Share Analysis, By End-User
  7. GEOGRAPHICAL ANALYSIS
    1. Introduction
      1. Regional Trends
      2. Impact Analysis
      3. Y-o-Y Growth Analysis
      4. Market Attractiveness Analysis
      5. Market Share Analysis
    2. Asia-Pacific
      1. Introduction
      2. China
      3. India
      4. Japan
      5. South Korea
      6. Australia and NZ
      7. Rest of APAC
  8. STRATEGIC ANALYSIS
    1. PESTLE analysis
      1. Political
      2. Economic
      3. Social
      4. Technological
      5. Legal
      6. Environmental
    2. Porter’s Five analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Consumers
      3. The threat of New Entrants
      4. The threat of Substitute Products and Services
      5. Competitive Rivalry within the Industry
  9. MARKET LEADERS' ANALYSIS
    1. Merck KGaA
      1. Overview
      2. Products
      3. Financials (subjected to availability based on company type)
      4. Recent Developments
      5. SWOT analysis
      6. Analyst View
    2. Thermo Fisher Scientific Inc.
    3. Lonza Group
    4. Osiris Therapeutics, Inc.
    5. Danaher Corporation
    6. Becton, Dickinson, and Company
    7. Sartorius AG
    8. Fresenius Medical Care AG & Co. KGaA
    9. FUJIFILM Irvine Scientific
    10. Corning Incorporated
    11. Mesoblast Ltd.
    12. Medipost Co., Ltd.
    13. Avantor, Inc.
    14. CellGenix GmbH
    15. Bio-Techne Corporation
    16. STEMCELL Technologies
    17. SIRION Biotech GmbH
    18. Hemasoft
  10. COMPETITIVE LANDSCAPE
    1. Market share analysis
    2. Merger and Acquisition Analysis
    3. Agreements, Collaborations and Joint Ventures
    4. New Product Launches
  11. MARKET OUTLOOK AND INVESTMENT OPPORTUNITIES
  12. APPENDIX
    1. List of Tables
    2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • The segment-level analysis in terms of technology, type, cell source, application, end-users along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analyzing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Cell Therapy Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  3. Global Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Cell Immortalization Technology
  5. Market, By Region, From 2021 to 2026 (USD Billion)
  6. Global Viral Vector Technology
  7. Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  10. Global Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  12. Global Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  15. Global iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Umbilical Cord Blood-Derived Cells
  18. Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  21. Global Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  22. Global Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  23. Global Cardiovascular
  24. Market, By Region, From 2021 to 2026 (USD Billion)
  25. Global Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  26. Global Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  27. Global Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  28. Global Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  29. Global Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  30. Global Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  31. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  32. Global Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  33. Global Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  34. Global Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  35. Global Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  36. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  37. North America Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  38. North America Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Cell Immortalization Technology
  40. Market, By Region, From 2021 to 2026 (USD Billion)
  41. North America Viral Vector Technology
  42. Market, By Region, From 2021 to 2026 (USD Billion)
  43. North America Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  44. North America Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  45. North America Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  46. North America Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  47. North America Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  48. North America Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  49. North America Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  50. North America iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  51. North America Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  52. North America Umbilical Cord Blood-Derived Cells
  53. Market, By Region, From 2021 to 2026 (USD Billion)
  54. North America Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  55. North America Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  56. North America Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  57. North America Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  58. North America Cardiovascular
  59. Market, By Region, From 2021 to 2026 (USD Billion)
  60. North America Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  61. North America Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  62. North America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  63. North America Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  64. North America Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  65. North America Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  66. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  67. North America Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  68. North America Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  69. North America Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  70. North America Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  71. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  72. United States Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  73. United States Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  74. United States Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  75. United States Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  76. United States Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  77. Canada Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  78. Canada Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  79. Canada Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  80. Canada Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  81. Canada Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  82. Europe Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  83. Europe Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  84. Europe Cell Immortalization Technology
  85. Market, By Region, From 2021 to 2026 (USD Billion)
  86. Europe Viral Vector Technology
  87. Market, By Region, From 2021 to 2026 (USD Billion)
  88. Europe Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  89. Europe Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  90. Europe Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  91. Europe Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  92. Europe Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  93. Europe Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  94. Europe Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  95. Europe iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  96. Europe Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  97. Europe Umbilical Cord Blood-Derived Cells
  98. Market, By Region, From 2021 to 2026 (USD Billion)
  99. Europe Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  100. Europe Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  101. Europe Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  102. Europe Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  103. Europe Cardiovascular
  104. Market, By Region, From 2021 to 2026 (USD Billion)
  105. Europe Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  106. Europe Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  107. Europe Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  108. Europe Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  109. Europe Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  110. Europe Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  111. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  112. Europe Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  113. Europe Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  114. Europe Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  115. Europe Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  116. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  117. U.K. Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  118. U.K. Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  119. U.K. Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  120. U.K. Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  121. U.K. Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  122. Germany Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  123. Germany Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  124. Germany Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  125. Germany Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  126. Germany Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  127. France Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  128. France Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  129. France Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  130. France Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  131. France Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  132. Italy Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  133. Italy Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  134. Italy Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  135. Italy Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  136. Italy Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  137. Spain Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  138. Spain Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  139. Spain Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  140. Spain Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  141. Spain Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  142. Asia Pacific Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  143. Asia Pacific Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  144. Asia Pacific Cell Immortalization Technology
  145. Market, By Region, From 2021 to 2026 (USD Billion)
  146. Asia Pacific Viral Vector Technology
  147. Market, By Region, From 2021 to 2026 (USD Billion)
  148. Asia Pacific Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  149. Asia Pacific Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  150. Asia Pacific Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  151. Asia Pacific Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  152. Asia Pacific Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  153. Asia Pacific Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  154. Asia Pacific Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  155. Asia Pacific iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  156. Asia Pacific Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  157. Asia Pacific Umbilical Cord Blood-Derived Cells
  158. Market, By Region, From 2021 to 2026 (USD Billion)
  159. Asia Pacific Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  160. Asia Pacific Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  161. Asia Pacific Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  162. Asia Pacific Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  163. Asia Pacific Cardiovascular
  164. Market, By Region, From 2021 to 2026 (USD Billion)
  165. Asia Pacific Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  166. Asia Pacific Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  167. Asia Pacific Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  168. Asia Pacific Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  169. Asia Pacific Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  170. Asia Pacific Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  171. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  172. Asia Pacific Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  173. Asia Pacific Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  174. Asia Pacific Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  175. Asia Pacific Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  176. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  177. Japan Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  178. Japan Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  179. Japan Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  180. Japan Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  181. Japan Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  182. China Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  183. China Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  184. China Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  185. China Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  186. China Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  187. India Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  188. India Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  189. India Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  190. India Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  191. India Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  192. Australia Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  193. Australia Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  194. Australia Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  195. Australia Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  196. Australia Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  197. South Korea Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  198. South Korea Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  199. South Korea Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  200. South Korea Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  201. South Korea Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  202. Latin America Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  203. Latin America Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  204. Latin America Cell Immortalization Technology
  205. Market, By Region, From 2021 to 2026 (USD Billion)
  206. Latin America Viral Vector Technology
  207. Market, By Region, From 2021 to 2026 (USD Billion)
  208. Latin America Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  209. Latin America Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  210. Latin America Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  211. Latin America Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  212. Latin America Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  213. Latin America Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  214. Latin America Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  215. Latin America iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  216. Latin America Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  217. Latin America Umbilical Cord Blood-Derived Cells
  218. Market, By Region, From 2021 to 2026 (USD Billion)
  219. Latin America Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  220. Latin America Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  221. Latin America Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  222. Latin America Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  223. Latin America Cardiovascular
  224. Market, By Region, From 2021 to 2026 (USD Billion)
  225. Latin America Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  226. Latin America Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  227. Latin America Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  228. Latin America Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  229. Latin America Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  230. Latin America Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  231. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  232. Latin America Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  233. Latin America Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  234. Latin America Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  235. Latin America Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  236. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  237. Brazil Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  238. Brazil Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  239. Brazil Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  240. Brazil Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  241. Brazil Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  242. Argentina Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  243. Argentina Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  244. Argentina Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  245. Argentina Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  246. Argentina Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  247. Mexico Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  248. Mexico Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  249. Mexico Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  250. Mexico Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  251. Mexico Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  252. Rest of Latin America Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  253. Rest of Latin America Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  254. Rest of Latin America Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  255. Rest of Latin America Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  256. Rest of Latin America Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  257. Middle East and Africa Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  258. Middle East and Africa Somatic Cell Technology Market, By Region, From 2021 to 2026 (USD Billion)
  259. Middle East and Africa Cell Immortalization Technology
  260. Market, By Region, From 2021 to 2026 (USD Billion)
  261. Middle East and Africa Viral Vector Technology
  262. Market, By Region, From 2021 to 2026 (USD Billion)
  263. Middle East and Africa Genome Editing Technology Market, By Region, From 2021 to 2026 (USD Billion)
  264. Middle East and Africa Cell Plasticity Technology Market, By Region, From 2021 to 2026 (USD Billion)
  265. Middle East and Africa Three-Dimensional Technology Market, By Region, From 2021 to 2026 (USD Billion)
  266. Middle East and Africa Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  267. Middle East and Africa Autologous Market, By Region, From 2021 to 2026 (USD Billion)
  268. Middle East and Africa Allogeneic Market, By Region, From 2021 to 2026 (USD Billion)
  269. Middle East and Africa Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  270. Middle East and Africa iPSCs Market, By Region, From 2021 to 2026 (USD Billion)
  271. Middle East and Africa Bone Marrow Market, By Region, From 2021 to 2026 (USD Billion)
  272. Middle East and Africa Umbilical Cord Blood-Derived Cells
  273. Market, By Region, From 2021 to 2026 (USD Billion)
  274. Middle East and Africa Adipose Tissues Market, By Region, From 2021 to 2026 (USD Billion)
  275. Middle East and Africa Neural Stem Cell Market, By Region, From 2021 to 2026 (USD Billion)
  276. Middle East and Africa Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  277. Middle East and Africa Musculoskeletal Market, By Region, From 2021 to 2026 (USD Billion)
  278. Middle East and Africa Cardiovascular
  279. Market, By Region, From 2021 to 2026 (USD Billion)
  280. Middle East and Africa Gastrointestinal Market, By Region, From 2021 to 2026 (USD Billion)
  281. Middle East and Africa Neurological Market, By Region, From 2021 to 2026 (USD Billion)
  282. Middle East and Africa Oncology Market, By Region, From 2021 to 2026 (USD Billion)
  283. Middle East and Africa Dermatology Market, By Region, From 2021 to 2026 (USD Billion)
  284. Middle East and Africa Wounds & Injuries Market, By Region, From 2021 to 2026 (USD Billion)
  285. Middle East and Africa Ocular Market, By Region, From 2021 to 2026 (USD Billion)
  286. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  287. Middle East and Africa Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  288. Middle East and Africa Hospitals & Clinics Market, By Region, From 2021 to 2026 (USD Billion)
  289. Middle East and Africa Regenerative Medicine Centres Market, By Region, From 2021 to 2026 (USD Billion)
  290. Middle East and Africa Diagnostic & Research Centres Market, By Region, From 2021 to 2026 (USD Billion)
  291. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  292. Middle East Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  293. Middle East Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  294. Middle East Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  295. Middle East Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  296. Middle East Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)
  297. Africa Cell Therapy Market, By Technology, From 2021 to 2026 (USD Billion)
  298. Africa Cell Therapy Market, By Type, From 2021 to 2026 (USD Billion)
  299. Africa Cell Therapy Market, By Cell Source, From 2021 to 2026 (USD Billion)
  300. Africa Cell Therapy Market, By Application, From 2021 to 2026 (USD Billion)
  301. Africa Cell Therapy Market, By End-User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4255

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample